Improving Women's Sexual Health While in Drug Addiction Treatment

在戒毒治疗期间改善女性的性健康

基本信息

  • 批准号:
    8737217
  • 负责人:
  • 金额:
    $ 21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-30 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Women treated for opioid dependence have a higher rate of unintended pregnancies (67%-86%) than the general population (49%). Given that opioid-dependent women have regular contact with health care providers during agonist-treatment, this setting is ideal for integrating unintended pregnancy interventions. Objective: The proximal goal of this R34 proposal is to develop and initially evaluate a social- cognitive, theory driven intervention, Sex and Female Empowerment (SAFE), designed to increase acceptance of and adherence to contraceptive practices among opioid-agonist- maintained women of childbearing age. SAFE comprises four 60-minute sessions that will be delivered in one of two formats: a face-to-face brief intervention approach or a novel, internet- based, computer-adaptive platform. The distal goal is to determine the extent to which either or both SAFE delivery formats yield long-term contraceptive practice improvements for women in substance abuse treatment. Design: The proposed study has three specific aims: Aim 1. To conduct individual interviews with providers of health services to opioid-agonist- maintained women of childbearing age, followed by focus groups and individual interviews with opioid-agonist-maintained women of childbearing age and opioid-agonist-maintained men in order to develop the content and structure of the SAFE intervention. Aim 2. To iteratively develop and pretest the SAFE intervention in a sample of women (N=36) assigned at random to either the face-to-face or computer-adaptive delivery format. SAFE's focus will be on increasing effective contraceptive use by (1) resolving ambivalence about contraceptive use and pregnancy through motivational interviewing (MI) techniques that will address pregnancy/childbearing motivation and planning challenges; (2) increasing contraceptive competence through male and female condom practice (on plastic models), receipt of emergency contraception prescription and MI style discussions about overcoming barriers to effective contraceptive use and contraceptive method side-effects; (3) reducing interpersonal violence risk through practicing effective partner communication, safer-sex negotiation, and physical and emotional safety techniques; and (4) immediate transport and escort to the Health Department for an evaluation for her contraceptive method(s) of choice. Aim 3. To conduct a small-scale, three-arm (face-to-face SAFE v. computer-adaptive SAFE v. usual care) randomized trial (N=90) to estimate effect sizes and determine the initial efficacy of both SAFE formats relative to each other and to usual care in terms of their relative impacts on (a) intervention completion, (b) intervention satisfaction, (c) contraceptive consultation appointment attendance, and (d) effective contraceptive method choice. Secondary foci include reproduction and contraceptive methods knowledge, contraceptive self-efficacy, effective contraceptive behavior, and risky sexual behavior. Summary: To the extent that either version of SAFE is found to be efficacious, it has the potential to reduce the number of unintended pregnancies and consequently decrease the need for and the costs of child protective services. Improving women's ability to make and adhere to contraceptive choices and better time their pregnancies while also decreasing risky sexual behavior that can lead to HIV and other sexually transmitted infections (STIs) adds to the promise of this interventions' potential overall public health impact.
描述(由申请人提供):接受阿片类药物依赖治疗的女性意外怀孕率(67%-86%)高于一般人群(49%)。鉴于阿片类药物依赖的妇女在激动剂治疗期间定期与卫生保健提供者接触,这种环境是整合意外怀孕干预措施的理想选择。目的:通过 R34提案的近期目标是发展和初步评估一种社会认知理论, 性和女性赋权(SAFE),旨在提高阿片类激动剂维持的育龄妇女对避孕做法的接受和坚持。SAFE包括四个60分钟的会议,将以两种形式之一提供:面对面的简短干预方法或新颖的基于互联网的计算机自适应平台。远端的目标是确定在何种程度上任一或两种安全的交付形式产生长期避孕措施的改善妇女的药物滥用治疗。设计:该研究有三个具体目标:目标1。对使用阿片类激动剂维持的育龄妇女的卫生服务提供者进行个别访谈,然后对使用阿片类激动剂维持的育龄妇女和使用阿片类激动剂维持的男性进行焦点小组和个别访谈,以制定SAFE干预措施的内容和结构。目标2.在随机分配到面对面或计算机自适应交付格式的女性样本(N=36)中迭代开发和预测试SAFE干预。SAFE的重点将是通过以下方式提高避孕药具的有效使用:(1)通过动机访谈技术解决避孕药具使用和怀孕的矛盾心理,这些技术将解决怀孕/生育动机和计划挑战;(2)通过使用男用和女用避孕套提高避孕能力(关于整形模特)、接受紧急避孕处方和关于克服有效使用避孕药具的障碍和避孕方法副作用的MI式讨论;(3)透过有效的伴侣沟通、安全性行为协商及身心安全技巧,减低人际暴力风险;及(4)立即将受害人送往卫生署接受评估,以决定其选择的避孕方法。目标3。进行一个小规模的三臂(面对面SAFE v.计算机自适应SAFE v.常规护理)随机试验(N=90),以估计效应量,并确定两种SAFE格式相对于彼此和常规护理的初始疗效,包括对(a)干预完成,(B)干预满意度,(c)避孕咨询预约出勤率,及(d)选择有效的避孕方法。次要焦点包括生殖和避孕方法知识、避孕自我效能、有效避孕行为和危险性行为。总结:如果发现SAFE的任何一个版本都有效,它都有可能减少意外怀孕的数量,从而减少对儿童保护服务的需求和费用。提高妇女做出和坚持避孕选择的能力,更好地安排怀孕时间,同时减少可能导致艾滋病毒和其他性传播感染的危险性行为,增加了这种干预措施潜在的整体公共卫生影响的希望。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hendree E Jones其他文献

Hendree E Jones的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hendree E Jones', 18)}}的其他基金

A comprehensive intervention to treat emerging drug-using populations
治疗新兴吸毒人群的综合干预措施
  • 批准号:
    10392901
  • 财政年份:
    2018
  • 资助金额:
    $ 21万
  • 项目类别:
A comprehensive intervention to treat emerging drug-using populations
治疗新兴吸毒人群的综合干预措施
  • 批准号:
    9920690
  • 财政年份:
    2018
  • 资助金额:
    $ 21万
  • 项目类别:
Improving Women's Sexual Health While in Drug Addiction Treatment
在戒毒治疗期间改善女性的性健康
  • 批准号:
    8911293
  • 财政年份:
    2013
  • 资助金额:
    $ 21万
  • 项目类别:
Improving Women's Sexual Health While in Drug Addiction Treatment
在戒毒治疗期间改善女性的性健康
  • 批准号:
    8460701
  • 财政年份:
    2013
  • 资助金额:
    $ 21万
  • 项目类别:
Treating South African Pregnant Women for Methamphetamine
南非孕妇接受甲基苯丙胺治疗
  • 批准号:
    8184625
  • 财政年份:
    2011
  • 资助金额:
    $ 21万
  • 项目类别:
HIV and Drug Use in Georgian Women
格鲁吉亚妇女的艾滋病毒和吸毒情况
  • 批准号:
    8494029
  • 财政年份:
    2010
  • 资助金额:
    $ 21万
  • 项目类别:
HIV and Drug Use in Georgian Women
格鲁吉亚妇女的艾滋病毒和吸毒情况
  • 批准号:
    8699347
  • 财政年份:
    2010
  • 资助金额:
    $ 21万
  • 项目类别:
HIV and Drug Use in Georgian Women
格鲁吉亚妇女的艾滋病毒和吸毒情况
  • 批准号:
    8287491
  • 财政年份:
    2010
  • 资助金额:
    $ 21万
  • 项目类别:
HIV and Drug Use in Georgian Women
格鲁吉亚妇女的艾滋病毒和吸毒情况
  • 批准号:
    8145624
  • 财政年份:
    2010
  • 资助金额:
    $ 21万
  • 项目类别:
HIV and Drug Use in Georgian Women
格鲁吉亚妇女的艾滋病毒和吸毒情况
  • 批准号:
    8728174
  • 财政年份:
    2010
  • 资助金额:
    $ 21万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了